AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9915318 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural alfentanil (400 microg bolus + a 400‐microg/h infusion for 2 h)
Number of subjects: 12
Study 9915318 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alfentanil (computer-controlled infusion)
Number of subjects: 12
Study 9915318 — intervention group
Group type: COMPARATOR
Intervention: Epidural saline
Number of subjects: 12
Study 9915318 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 12
Study 7844365 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine monotherapy or combination therapy with zidovudine
Number of subjects: 109
Study 7844365 — intervention group
Group type: EXPERIMENTAL
Intervention: QMC assay
Number of subjects: 109
Study 2216216 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg aspirin
Number of subjects: 47
Study 2216216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 31095263 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Sound Amplification Product (PSAP)
Number of subjects: 56
Study 31095263 — intervention group
Group type: COMPARATOR
Intervention: Basic Hearing Aid (HA)
Number of subjects: 56
Study 31095263 — intervention group
Group type: COMPARATOR
Intervention: Premium Hearing Aid (HA)
Number of subjects: 56
Study 28241133 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (intervention in a multicentre randomised placebo-controlled trial)
Number of subjects: 470
Study 28241133 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control in a multicentre randomised placebo-controlled trial)
Number of subjects: 470
Study 25219348 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-year intervention
Number of subjects: 979
Study 25219348 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 979
Study 23080373 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupported self-help CBT-I
Number of subjects: 479
Study 21406101 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl-prednisolone (MPDN)
Number of subjects: 56
Study 21406101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 21406101 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 56
Study 19332455 — intervention group
Group type: EXPERIMENTAL
Intervention: Early eptifibatide (two boluses of 180 microg/kg administered 10 minutes apart, and a standard infusion for >= 12 hours before angiography)
Number of subjects: 9492
Study 19332455 — intervention group
Group type: COMPARATOR
Intervention: Delayed eptifibatide (matching placebo infusion with provisional use after angiography)
Number of subjects: 9492
Study 19332455 — intervention group
Group type: EXPERIMENTAL
Intervention: Early eptifibatide
Number of subjects: 9492
Study 19332455 — intervention group
Group type: COMPARATOR
Intervention: Delayed eptifibatide
Number of subjects: 9492
Study 17357577 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha dihydroergocryptine (10 mg tablets)
Number of subjects: 77
Study 17357577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 15234134 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy, cryotherapy, and either complete (n = 8) or partial (n = 16) fluid-gas exchange. Patients with complete fluid-gas exchange were kept in a prone position for 6 hours; partial fluid-gas exchange patients were kept in a supine position with head elevated for 12 hours.
Number of subjects: 33
Study 15234134 — intervention group
Group type: COMPARATOR
Intervention: Episcleral buckle, cryotherapy, and, in selected cases, external drainage of subretinal fluid.
Number of subjects: 33
Study 11547705 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease Management Assistance System (electronic adherence device)
Number of subjects: 0
Study 11547705 — intervention group
Group type: COMPARATOR
Intervention: Monthly educational session (control)
Number of subjects: 0
Study 9429959 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational interventions and self-assessment questionnaires relating to smoking cessation
Number of subjects: 60
Study 9429959 — intervention group
Group type: COMPARATOR
Intervention: Routine information
Number of subjects: 60
Study 8272246 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtral device
Number of subjects: 0
Study 8272246 — intervention group
Group type: EXPERIMENTAL
Intervention: G120 M device
Number of subjects: 0
Study 8272246 — intervention group
Group type: COMPARATOR
Intervention: All dialysers
Number of subjects: 0
Study 3627593 — intervention group
Group type: EXPERIMENTAL
Intervention: Penile nerve block
Number of subjects: 30
Study 3627593 — intervention group
Group type: COMPARATOR
Intervention: No anesthesia (Control)
Number of subjects: 30
Study 29347946 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrotactile sensory augmentation during balance training
Number of subjects: 12
Study 29347946 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sensory augmentation)
Number of subjects: 12
Study 29347946 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12
Study 27742605 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative group (watched narrative cutscene before gameplay)
Number of subjects: 40
Study 27742605 — intervention group
Group type: COMPARATOR
Intervention: Non-narrative group (did not watch narrative cutscene)
Number of subjects: 40
Study 25039978 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole or AZD0865 (potent acid suppression treatment)
Number of subjects: 100
Study 25039978 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-grade reflux oesophagitis (A or B)
Number of subjects: 100
Study 25039978 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent regurgitation at baseline
Number of subjects: 100
Study 24376568 — intervention group
Group type: EXPERIMENTAL
Intervention: High Frequency electrical Stimulation (HFS)
Number of subjects: 19
Study 19498450 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation using fibrin glue (Tisseel)
Number of subjects: 70
Study 19498450 — intervention group
Group type: COMPARATOR
Intervention: 8-0 vicryl sutures
Number of subjects: 70
Study 18955430 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based training for three months with biweekly telephone monitoring
Number of subjects: 39
Study 18955430 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 17032283 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ATCC 55730 (10^8 CFU)
Number of subjects: 40
Study 17032283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 15042476 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease specific instruments (BELP‐KF, DMLQ)
Number of subjects: 44
Study 15042476 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ‐5D
Number of subjects: 44
Study 15042476 — intervention group
Group type: EXPERIMENTAL
Intervention: TTO
Number of subjects: 44
Study 15042476 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS
Number of subjects: 44
Study 15042476 — intervention group
Group type: COMPARATOR
Intervention: DMLQ
Number of subjects: 44
Study 15042476 — intervention group
Group type: COMPARATOR
Intervention: BELP‐KF
Number of subjects: 44
Study 11401810 — intervention group
Group type: EXPERIMENTAL
Intervention: Charge data provided to residents
Number of subjects: 23
Study 11401810 — intervention group
Group type: EXPERIMENTAL
Intervention: Group decision making with charge data
Number of subjects: 23
Study 11401810 — intervention group
Group type: COMPARATOR
Intervention: No charge data
Number of subjects: 23
Study 11401810 — intervention group
Group type: EXPERIMENTAL
Intervention: Charge data after ordering tests
Number of subjects: 23
Study 9296893 — intervention group
Group type: EXPERIMENTAL
Intervention: t‐PA and PAI‐1 concentrations in patients with type II diabetes
Number of subjects: 21
Study 9296893 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 21
Study 8513981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole (40 mg)
Number of subjects: 9
Study 8513981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole (80 mg)
Number of subjects: 9
Study 8513981 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 9
Study 3695448 — intervention group
Group type: COMPARATOR
Intervention: Constant Amplitude (CA)
Number of subjects: 0
Study 3695448 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoidally Modulated (SAM)
Number of subjects: 0
Study 3695448 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomly Modulated (RAM)
Number of subjects: 0
Study 31870125 — intervention group
Group type: EXPERIMENTAL
Intervention: Multichannel applicator for HDR vaginal brachytherapy
Number of subjects: 11
Study 28487318 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial coronary CTA strategy
Number of subjects: 1234
Study 28487318 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 1234
Study 25549768 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy (LH) or laparoscopically assisted vaginal hysterectomy (LAVH)
Number of subjects: 164
Study 25549768 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy (VH)
Number of subjects: 164
Study 22533516 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual therapy intervention
Number of subjects: 68
Study 22533516 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine management and educational programs)
Number of subjects: 68
Study 21362329 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose unfractionated heparin
Number of subjects: 607
Study 21362329 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin
Number of subjects: 607
Study 21362329 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 607
Study 21362329 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated compression stockings
Number of subjects: 607
Study 21362329 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression
Number of subjects: 607
Study 21362329 — intervention group
Group type: COMPARATOR
Intervention: VTE incidence
Number of subjects: 607
Study 21362329 — intervention group
Group type: COMPARATOR
Intervention: Mortality rate
Number of subjects: 607
Study 21362329 — intervention group
Group type: COMPARATOR
Intervention: Medical disorders contributing to VTE
Number of subjects: 607
Study 19731307 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose rituximab (375 mg/m2 x 4)
Number of subjects: 20
Study 19731307 — intervention group
Group type: COMPARATOR
Intervention: R-CVP (rituximab with cyclophosphamide, vincristine, and prednisone)
Number of subjects: 20
Study 19731307 — intervention group
Group type: COMPARATOR
Intervention: Double dose rituximab (DDR)
Number of subjects: 20
Study 16706755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifuga racemosa extract (CRS) applied twice daily for 3 months
Number of subjects: 32
Study 16706755 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue Nutrient Solution Recovery Complex (TNS) applied twice daily for 3 months
Number of subjects: 32
Study 16706755 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C (Vit C) cream applied twice daily for 3 months
Number of subjects: 32
Study 15053698 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct relations (auditory icons that use the sound made by the target event)
Number of subjects: 0
Study 15053698 — intervention group
Group type: COMPARATOR
Intervention: Indirect relations (ecological, metaphorical, and random)
Number of subjects: 0
Study 11397885 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% lipid emulsion infusion + heparin (n = 15)
Number of subjects: 30
Study 11397885 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control study; n = 15)
Number of subjects: 30
Study 11397885 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified insulin treatment after 3 months (n = 30)
Number of subjects: 30
Study 9779369 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects (group 1)
Number of subjects: 0
Study 9779369 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with achalasia (group 2)
Number of subjects: 0
Study 9779369 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0
Study 9779369 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 0
Study 7944453 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy (IP)
Number of subjects: 16
Study 7944453 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraaortic chemotherapy (IA)
Number of subjects: 16
Study 7944453 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 3331044 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin
Number of subjects: 210
Study 3331044 — intervention group
Group type: COMPARATOR
Intervention: Amikacin plus piperacillin
Number of subjects: 210
Study 29314705 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Homestead Food Production (EHFP)
Number of subjects: 900
Study 29314705 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Homestead Food Production plus Aquaculture (EHFP + Aquaculture)
Number of subjects: 900
Study 29314705 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 900
Study 27689610 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise rehabilitation
Number of subjects: 14
Study 24490025 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole (16-24 mg)
Number of subjects: 9
Study 24490025 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine (10-20 mg)
Number of subjects: 9
Study 24490025 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 9
Study 24490025 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 9
Study 23137020 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin pad
Number of subjects: 17
Study 23137020 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC)
Number of subjects: 17
Study 20728522 — intervention group
Group type: EXPERIMENTAL
Intervention: gp120/NefTat candidate HIV-1 vaccine with AS01(B)
Number of subjects: 0
Study 20728522 — intervention group
Group type: EXPERIMENTAL
Intervention: gp120/NefTat candidate HIV-1 vaccine with AS02(A)
Number of subjects: 0
Study 20728522 — intervention group
Group type: EXPERIMENTAL
Intervention: gp120/NefTat candidate HIV-1 vaccine with AS02(V)
Number of subjects: 0
Study 20728522 — intervention group
Group type: EXPERIMENTAL
Intervention: gp120/NefTat candidate HIV-1 vaccine
Number of subjects: 0
Study 18991469 — intervention group
Group type: EXPERIMENTAL
Intervention: LNX‐QR 8 mg tablet
Number of subjects: 200
Study 18991469 — intervention group
Group type: EXPERIMENTAL
Intervention: LNX‐ST 8 mg tablet
Number of subjects: 200
Study 18991469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 15825930 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong argument with celebrity spokesperson
Number of subjects: 0
Study 15825930 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong argument with noncelebrity spokesperson
Number of subjects: 0
Study 15825930 — intervention group
Group type: EXPERIMENTAL
Intervention: Weak argument with celebrity spokesperson
Number of subjects: 0
Study 15825930 — intervention group
Group type: EXPERIMENTAL
Intervention: Weak argument with noncelebrity spokesperson
Number of subjects: 0
Study 15825930 — intervention group
Group type: COMPARATOR
Intervention: Inner-directed subjects
Number of subjects: 0
Study 15825930 — intervention group
Group type: EXPERIMENTAL
Intervention: Argument strength (strong vs weak)
Number of subjects: 0
Study 12887004 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable membrane (RXT group)
Number of subjects: 12
Study 12887004 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive glass (PG group)
Number of subjects: 12
Study 11798692 — intervention group
Group type: EXPERIMENTAL
Intervention: Losec (40 mg)
Number of subjects: 18
Study 11798692 — intervention group
Group type: COMPARATOR
Intervention: Aoke‐Changzhou No.4 Pharm (40 mg)
Number of subjects: 18
Study 11798692 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole‐Sanye Pharm (40 mg)
Number of subjects: 18
Study 8683228 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential methotrexate and fluorouracil (M‐‐>F)
Number of subjects: 1855
Study 8683228 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide, methotrexate, and fluorouracil (CMF)
Number of subjects: 1855
Study 1806728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp time of 1.0 seconds
Number of subjects: 47
Study 1806728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp time of 3.5 seconds
Number of subjects: 47
Study 1806728 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp time of 5.0 seconds
Number of subjects: 47
Study 6348763 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids or chlorambucil given in alternate months for a cumulative period of six months
Number of subjects: 49
Study 6348763 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy (Control)
Number of subjects: 49
Study 6348763 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids or chlorambucil
Number of subjects: 49
Study 31373314 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention on nutrition, hygiene, and stimulation
Number of subjects: 155
Study 31373314 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 155
Study 29703800 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-based blood pressure monitoring
Number of subjects: 206
Study 29703800 — intervention group
Group type: COMPARATOR
Intervention: Usual care blood pressure check at prenatal clinic
Number of subjects: 206
Study 27621394 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/day
Number of subjects: 410
Study 27621394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study 25367235 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg administered 2 minutes before aortic declamping)
Number of subjects: 86
Study 25367235 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (300 mg intravenously administered 15 minutes before release of aortic cross clamp)
Number of subjects: 86
Study 25367235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 86
Study 25367235 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine and Placebo (when ventricular fibrillation occurred)
Number of subjects: 86
Study 25367235 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (when ventricular fibrillation occurred)
Number of subjects: 86
Study 22965962 — intervention group
Group type: EXPERIMENTAL
Intervention: (ziv‐)aflibercept 6 mg/kg IV + docetaxel 75 mg/m²
Number of subjects: 913
Study 22965962 — intervention group
Group type: COMPARATOR
Intervention: Placebo + docetaxel 75 mg/m²
Number of subjects: 913
Study 19826792 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind paroxetine (DBPX)
Number of subjects: 30
Study 19826792 — intervention group
Group type: COMPARATOR
Intervention: Single-blind paroxetine (SBPX)
Number of subjects: 30
Study 19826792 — intervention group
Group type: COMPARATOR
Intervention: Double-blind placebo (DBPO)
Number of subjects: 30
Study 16091055 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg once daily
Number of subjects: 477
Study 16091055 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 20 mg on-demand
Number of subjects: 477
Study 12590989 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored interventions (telephone counseling, in-person counseling, physician letter, combinations of telephone with letter and in-person with letter)
Number of subjects: 773
Study 12590989 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of in-person with physician letter
Number of subjects: 773
Study 12590989 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 773
Study 12590989 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored interventions
Number of subjects: 773
Study 10496434 — intervention group
Group type: EXPERIMENTAL
Intervention: d,l-sotalol 80 mg twice daily
Number of subjects: 253
Study 10496434 — intervention group
Group type: EXPERIMENTAL
Intervention: d,l-sotalol 120 mg twice daily
Number of subjects: 253
Study 10496434 — intervention group
Group type: EXPERIMENTAL
Intervention: d,l-sotalol 160 mg twice daily
Number of subjects: 253
Study 10496434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study 7847565 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol exposure
Number of subjects: 542
Study 7847565 — intervention group
Group type: COMPARATOR
Intervention: Unexposed women
Number of subjects: 542
Study 1745318 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 9 g/24 hours
Number of subjects: 37
Study 1745318 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 6 g/24 hours
Number of subjects: 37
Study 1745318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 7082204 — intervention group
Group type: EXPERIMENTAL
Intervention: Lensectomy and anterior vitrectomy
Number of subjects: 27
Study 7082204 — intervention group
Group type: COMPARATOR
Intervention: Discission and aspiration
Number of subjects: 27
Study 31277184 — intervention group
Group type: EXPERIMENTAL
Intervention: 25G needle through the lateral crypt (group L, n=30)
Number of subjects: 60
Study 31277184 — intervention group
Group type: COMPARATOR
Intervention: 25G needle in a vertical approach (group C, n=30)
Number of subjects: 60
Study 28704286 — intervention group
Group type: EXPERIMENTAL
Intervention: Force Feedback (FFB)
Number of subjects: 101
Study 28704286 — intervention group
Group type: COMPARATOR
Intervention: No Force Feedback (Control)
Number of subjects: 101
Study 25646363 — intervention group
Group type: EXPERIMENTAL
Intervention: PLB fixation at 0° (P0)
Number of subjects: 90
Study 25646363 — intervention group
Group type: EXPERIMENTAL
Intervention: PLB fixation at 20° (P20)
Number of subjects: 90
Study 25646363 — intervention group
Group type: EXPERIMENTAL
Intervention: PLB fixation at 45° (P45)
Number of subjects: 90
Study 25646363 — intervention group
Group type: COMPARATOR
Intervention: Comparison of P20 vs P45
Number of subjects: 90
Study 25646363 — intervention group
Group type: COMPARATOR
Intervention: Comparison of P0 vs P45
Number of subjects: 90